Related Experiment Video

Updated: Aug 1, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

Dexamethasone for pulmonary interstitial emphysema in preterm infants

D Fitzgerald1, D Willis, R Usher

  • 1Montreal Children's Hospital, Quebec, Canada.

Biology of the Neonate
|February 12, 1998
PubMed

Insights

A short course of dexamethasone effectively treated pulmonary interstitial emphysema (PIE) in preterm infants. This treatment significantly improved respiratory support and outcomes, with most infants surviving to term.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Pharmacology

Background:

  • Pulmonary interstitial emphysema (PIE) is a serious condition in preterm infants.
  • Current treatments for PIE have limitations and variable efficacy.
  • The role of corticosteroids in managing PIE requires further investigation.

Purpose of the Study:

  • To evaluate the efficacy of a 3-day course of dexamethasone in preterm infants with PIE.
  • To assess the impact of dexamethasone on respiratory support parameters and clinical outcomes.
  • To explore potential mechanisms of action for dexamethasone in PIE.

Main Methods:

  • Retrospective case review of 10 preterm infants (< or = 30 weeks gestation) diagnosed with PIE.
  • Treatment involved a 3-day course of dexamethasone (0.5 mg/kg/day).
  • Respiratory parameters including mean airway pressure (MAP), oxygenation index (OI), and mechanical ventilation index (MVI) were analyzed before and after treatment.

Main Results:

  • Significant improvements in OI, MAP, FiO2, and MVI were observed within 3 days of dexamethasone treatment (p < 0.05).
  • PIE resolved on chest X-ray in 78% of infants and improved in 22% by day 7.
  • Nine out of 10 infants survived to term, indicating a positive impact on survival.

Conclusions:

  • A 3-day course of dexamethasone is associated with significant clinical improvement in preterm infants with PIE.
  • Dexamethasone may exert its effects by reducing airway edema, inflammation, and obstruction.
  • This short-term corticosteroid regimen shows promise as an effective treatment for PIE in this vulnerable population.

More Related Videos

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease04:21

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease

Published on: August 4, 2021

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...